Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Highly Accessed Letter

Number needed to treat for subglottic secretion drainage technology as a ventilator-associated pneumonia prevention strategy

Scott D Kelley

Author Affiliations

Respiratory and Monitoring Solutions, Covidien, 6135 Gunbarrel Dr., Boulder, CO 80301, USA

Critical Care 2012, 16:446  doi:10.1186/cc11464

Published: 4 September 2012

Abstract

The number needed to treat can be calculated for ventilator-associated pneumonia reduction strategies such as subglottic secretion drainage technology based on previous work establishing its relative risk reduction. Assuming an incidence of 4%, employing subglottic secretion drainage in 33 patients will prevent one case of ventilator-associated pneumonia, and thus potentially 4 cases annually in an average hospital in the United States. With a previously described limit of £300 ($470 USD) additional cost per 10 days of ventilation as a threshold of investment for technologies to reduce ventilator-associated pneumonia, subglottic secretion drainage technology is both clinically and cost effective.